<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04533295</url>
  </required_header>
  <id_info>
    <org_study_id>2019CR110</org_study_id>
    <nct_id>NCT04533295</nct_id>
  </id_info>
  <brief_title>The Effect of Acupuncture on IVF Pregnancy Outcomes for Women With RIF</brief_title>
  <official_title>The Effect of Acupuncture on IVF Pregnancy Outcomes for Women With Recurrent Implantation Failure: a Multi-center Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The randomized, placebo-controlled multicenter trial is conducted in five centers in China.&#xD;
      After screening and obtaining the signed informed consent , the participants are randomly&#xD;
      divided into two groups: acupuncture +IVF group and sham acupuncture +IVF group.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 11, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CPR</measure>
    <time_frame>1 month after ET</time_frame>
    <description>Clinical pregnancy rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>OPR</measure>
    <time_frame>3 month after ET</time_frame>
    <description>ongoing pregnancy rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LBR</measure>
    <time_frame>10 month after ET</time_frame>
    <description>Live birth rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical indexes</measure>
    <time_frame>one year</time_frame>
    <description>Biochemical indexes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire score</measure>
    <time_frame>one year</time_frame>
    <description>Questionnaire score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">514</enrollment>
  <condition>Repeated Implantation Failure</condition>
  <arm_group>
    <arm_group_label>Acupuncture and IVF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acupuncture and IVF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham acupuncture and IVF</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham acupuncture and IVF</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>acupuncture and IVF</intervention_name>
    <description>Acupuncture was performed three times a week for 30 minutes each time, starting from the 5th day of menstruation and ending within 24 hours after embryo transfer.</description>
    <arm_group_label>Acupuncture and IVF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham acupuncture and IVF</intervention_name>
    <description>Sham acupuncture was performed three times a week for 30 minutes each time, starting from the 5th day of menstruation and ending within 24 hours after embryo transfer.</description>
    <arm_group_label>Sham acupuncture and IVF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Married women aged 25-40;&#xD;
&#xD;
          2. Repeated implantation failure for unknown reasons (after 3 or more consecutive cycles&#xD;
             of embryo transfer, or cumulative transfer of ≥6 high-quality cleavage embryos or 4&#xD;
             high-quality blastocysts without clinical pregnancy);&#xD;
&#xD;
          3. Transplantable Day 3 high-quality frozen embryos or frozen blastocysts (≥3BB);&#xD;
&#xD;
          4. Estrogen and progesterone replacement therapy (HRT), endometrial thickness ≥7mm on the&#xD;
             day of endometrial transformation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients who met any of the following conditions were not included.&#xD;
&#xD;
          1. Those who prepare for PGD;&#xD;
&#xD;
          2. Recipients of egg donors;&#xD;
&#xD;
          3. Chromosomal abnormalities in both or one of the couples (excluding chromosome&#xD;
             polymorphism);&#xD;
&#xD;
          4. patients with implantation failure due to known embryonic factors;&#xD;
&#xD;
          5. Uterine lesions that may affect implantation (including uterine malformation, uterine&#xD;
             tuberculosis, history of intrauterine adhesions, submucosal fibroids, adenomyosis,&#xD;
             &gt;4cm intramural fibroids)&#xD;
&#xD;
          6. Repeated spontaneous abortion (2 or more fetal loss before 28 weeks of gestation);&#xD;
&#xD;
          7. Patients with other endocrine diseases, such as thyroid disease, hyperprolactinemia,&#xD;
             insulin resistance, diabetes, adrenal disease, etc., and poor control of hormone&#xD;
             levels in the last 3 months;&#xD;
&#xD;
          8. Clearly diagnosed autoimmune diseases such as systemic lupus erythematosus, rheumatoid&#xD;
             arthritis, antiphospholipid syndrome, etc.;&#xD;
&#xD;
          9. Hydrosalpinx untreated;&#xD;
&#xD;
         10. BMI less than 18 and higher than 25kg/m2;&#xD;
&#xD;
         11. People with previous history of needle sickness;&#xD;
&#xD;
         12. Those who had previously participated in this study or had received acupuncture&#xD;
             treatment in the past 3 months.&#xD;
&#xD;
         13. Any situation that researchers consider inappropriate for participating in this study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Minming Zhang, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huazhong University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cuihong Zheng, professor</last_name>
    <phone>86-27-83663275</phone>
    <email>chzheng@tjh.tjmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tongji Hospital,Tongji medical college,HUST</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cuihong Zheng, professor</last_name>
    </contact>
    <investigator>
      <last_name>Minming Zhang, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2020</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huazhong University of Science and Technology</investigator_affiliation>
    <investigator_full_name>Cui Hong Zheng</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

